{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-078795","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.678917+00:00","generated_at":"2026-06-01T00:46:09.256656+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Candel Therapeutics stockholders elect three Class III directors and ratify KPMG as auditor","bullets":["Nicoletta Loggia (7.18M for), Christopher Martell (6.99M for), Diem Nguyen (7.02M for) elected as Class III directors.","KPMG LLP ratified as independent auditor for fiscal 2024 with 14.62M for, 98.9K against, 42.9K abstain.","Meeting held June 26, 2024; record date May 15, 2024; 29.76M shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-078795","json":"https://secwatch.observer/filing/0000950170-24-078795.json","markdown":"https://secwatch.observer/filing/0000950170-24-078795.md","text":"https://secwatch.observer/filing/0000950170-24-078795.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000095017024078795/0000950170-24-078795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000095017024078795/cadl-20240626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:46:09.256656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}